Skip to content
TrialScanner

NCT04147650

Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome

Phase 2/Phase 3CompletedAUPHLead

Registry record

Lead sponsor
Aurinia Pharmaceuticals Inc.
Conditions
Dry Eye Syndrome; Keratoconjunctivitis Sicca
Primary completion
Sep 17, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04147650 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04147650: Dose Ranging Study to Assess... | TrialScanner